Activist 13D/13G Filings - ARS Pharmaceuticals Inc. (SPRY)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-01-27
3:05 pm
Sale
13DARS PHARMACEUTICALS, INC
SPRY
U.S. Venture Partners XII L.P.110,120
0.3%
-2,160,360decrease
(-95.15%)
View
2021-02-16
4:39 pm
Purchase
13GARS PHARMACEUTICALS, INC
SPRY
RA CAPITAL MANAGEMENT L.P.1,742,186
5%
1,742,186increase
(New Position)
View
2021-02-16
4:01 pm
Purchase
13GARS PHARMACEUTICALS, INC
SPRY
NEXTECH VI ONCOLOGY SCSP1,910,029
5.5%
1,910,029increase
(New Position)
View
2021-02-10
09:23 am
Purchase
13GARS PHARMACEUTICALS, INC
SPRY
FMR LLC4,259,612
12.243%
818,308increase
(+23.78%)
View
2021-02-08
10:33 am
Purchase
13GARS PHARMACEUTICALS, INC
SPRY
FMR LLC3,441,304
9.891%
3,441,304increase
(New Position)
View
2021-01-04
4:42 pm
Purchase
13GARS PHARMACEUTICALS, INC
SPRY
EcoR1 Capital LLC2,533,635
7.3%
2,533,635increase
(New Position)
View
2020-12-18
07:22 am
Purchase
13GARS PHARMACEUTICALS, INC
SPRY
Boxer Capital LLC1,675,377
4.8%
3increase
(+0.00%)
View
2020-12-17
4:37 pm
Purchase
13GARS PHARMACEUTICALS, INC
SPRY
Boxer Capital LLC1,675,374
4.8%
1,675,374increase
(New Position)
View
2020-12-14
06:05 am
Purchase
13DARS PHARMACEUTICALS, INC
SPRY
U.S. Venture Partners XII L.P.2,270,480
6.5%
2,270,480increase
(New Position)
View
2020-12-11
4:47 pm
Purchase
13DARS PHARMACEUTICALS, INC
SPRY
ORBIMED ADVISORS LLC7,788,511
22.4%
7,788,511increase
(New Position)
View
Goto Prev, 0, 1